We are Locate Bio, and we are building next-generation products for surgeons, so they can relieve suffering and restore quality of life for the 1.7Bn people around the globe who suffer from muscular-skeletal conditions.
Our main areas of focus are on:
- Retaining mobility among the rapidly ageing global population with a controlled and extended-release therapeutic protein for chronic low back pain.
- Targeting resistant orthopaedic biofilm infections, initially for treating periprosthetic joint infections.
Our strategy is to only develop next-generation products capable of dominating each of their market segments.
To achieve this, we use our two core competencies to develop exciting new products with breakthrough performance. These two competencies are
- Programmed Drug Release and
- Instructive Tissues Scaffolds
Programmed Drug Release is the modification of the bioavailability of drugs to better match the underlying biological needs. For us, this means working with well-characterised molecules and controlling and extending their release profiles.
Instructive Tissue Scaffolds are biomaterials which, through geometric clues are able to influence cell fate and healing, without the aid of drugs of exogenous stem cells.